Does Analyst Optimism Around On (ONON) Mask Deeper Questions About Its DTC-Led Profit Model?
On Holding ONON | 0.00 |
- In recent days, On Holding AG has attracted heightened attention as analysts reiterated positive views ahead of its past ICR Conference 2026 presentation in Orlando, where CEO & CFO Martin Hoffmann outlined the brand’s progress in premium performance and lifestyle footwear.
- This flurry of research updates, set against mixed near-term earnings expectations but continued strength in direct-to-consumer and international expansion, has sharpened the debate over how durable On’s growth and profitability profile may be.
- Against this backdrop, we’ll explore how renewed analyst optimism around On’s direct-to-consumer shift shapes the company’s broader investment narrative.
AI is about to change healthcare. These 109 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
On Holding Investment Narrative Recap
To own On Holding, you have to believe the brand can keep scaling premium performance and lifestyle footwear while improving profitability through its growing direct to consumer mix. The key near term catalyst is evidence that this shift can offset mixed earnings expectations, while the biggest current risk is that heavy investment in global expansion and innovation compresses margins if demand softens. The recent analyst optimism around the ICR 2026 appearance does not materially change those core drivers.
Among recent announcements, the reiterated Buy ratings and higher price targets from firms such as Bernstein, UBS and Telsey Advisory are most relevant, because they directly reflect how the market is weighing On’s DTC acceleration and global growth against near term earnings volatility. At the same time, the Zacks Rank #4 (Sell) underlines that not all observers are aligned on how near term profitability will track these growth investments.
Yet beneath the upbeat long term brand story, the risk that rising premium prices and cost pressures could eventually test consumer tolerance is something investors should be aware of...
On Holding's narrative projects CHF5.0 billion revenue and CHF561.2 million earnings by 2028. This requires 22.9% yearly revenue growth and an earnings increase of about CHF425 million from CHF135.9 million.
Uncover how On Holding's forecasts yield a $62.34 fair value, a 38% upside to its current price.
Exploring Other Perspectives
Eighteen Simply Wall St Community fair value estimates for On range from US$45.33 to US$87.90, showing very different views on upside. Set those alongside the mixed analyst signals on earnings and margins, and it becomes clear you should compare several perspectives before deciding how On’s growth investments might affect future performance.
Explore 18 other fair value estimates on On Holding - why the stock might be worth just $45.33!
Build Your Own On Holding Narrative
Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.
- A great starting point for your On Holding research is our analysis highlighting 3 key rewards that could impact your investment decision.
- Our free On Holding research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate On Holding's overall financial health at a glance.
Contemplating Other Strategies?
Every day counts. These free picks are already gaining attention. See them before the crowd does:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 24 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.
- These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
